Sanofi India appoints Vaibhav Karandikar as Chief Financial Officer

Published On 2020-10-06 06:30 GMT   |   Update On 2020-10-06 08:58 GMT

Mumbai: Drug major, Sanofi India has recently announced that the Board of Directors of the Company at its meeting held on 5 th October 2020 approved the appointment of Mr. Vaibhav Karandikar as Chief Financial Officer and Key Managerial Personnel with effect from 6 th October 2020. Mr. Vaibhav Karandikar is a Chartered Accountant, a Company Secretary and a Cost Accountant with 25...

Login or Register to read the full article

Mumbai: Drug major, Sanofi India has recently announced that the Board of Directors of the Company at its meeting held on 5 th October 2020 approved the appointment of Mr. Vaibhav Karandikar as Chief Financial Officer and Key Managerial Personnel with effect from 6 th October 2020.

Mr. Vaibhav Karandikar is a Chartered Accountant, a Company Secretary and a Cost Accountant with 25 years' experience across various domains in Finance.
He joined Sanofi in April 2007 in the Accounting & Taxation function, subsequently of which he became the Head. In his most recent assignment, he worked as Head of Controlling for the General Medicines Business (including Consumer Healthcare).
In this role, he also supported the Global Support Function activities, Intra-Group Export and Intra-Group services. During his time at Sanofi, he has been part of several key assignments/projects including mergers, acquisitions, divestures as well as GST transition. Prior to joining Sanofi, he worked as Senior Manager - Finance & Company Secretary - Sandoz India.
In the past, he was associated with Aventis Pharma Limited, Tata Power Company Limited and Hindustan Ciba Geigy.

Read also: Nikhil Chopra appointed as Director, CEO of J B Chemicals





Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News